Differences in the preferred antipsychotics for acute schizophrenia among young psychiatrists in two regions of Japan

Asian Journal of Psychiatry

Volumn 3, Issue 2, 2010, Pages 60-63

  Tateno, Masaru ^a   Kato, Takahiro ^b   Nakano, Wakako ^c   Kanba, Shigenobu ^b   Nakamura, Jun ^c   Saito, Toshikazu ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Acute schizophrenia; Atypical antipsychotics; Haloperidol; Olanzapine; Risperidone

Indexed keywords

HALOPERIDOL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ARTICLE; CONTROLLED STUDY; DRUG CHOICE; HUMAN; JAPAN; MEDICAL EDUCATION; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; SCHIZOPHRENIA; VIGNETTE;

EID: 77953289181     PISSN: 18762018     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajp.2010.03.005     Document Type: Article

References (21)

1. Allen M.H., Currier G.W., Carpenter D., Ross R.W., and Docherty J.P. The expert consensus guideline series. Treatment of behavioral emergencies 2005. J. Psychiatr. Pract. 11 Suppl 1 (2005) 5-108 quiz 110-102
2. Asai K. From mental health law to mental health and welfare law. Psychiatry Clin. Neurosci. 52 (1998) S247-S249 Suppl
3. Currier G.W., and Simpson G.M. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. J. Clin. Psychiatry 62 3 (2001) 153-157
4. Gaebel W., Weinmann S., Sartorius N., Rutz W., and McIntyre J.S. Schizophrenia practice guidelines: international survey and comparison. Br. J. Psychiatry 187 (2005) 248-255
5. Hatta K., Kawabata T., Yoshida K., Hamakawa H., Wakejima T., Furuta K., Nakamura M., Hirata T., Usui C., Nakamura H., and Sawa Y. Olanzapine orally disintegrating tablet vs. risperidone oral solution in the treatment of acutely agitated psychotic patients. Gen. Hosp. Psychiatry 30 4 (2008) 367-371
6. Ito H., Koyama A., and Higuchi T. Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription. Br. J. Psychiatry 187 (2005) 243-247
7. Lehman A.F., Lieberman J.A., Dixon L.B., McGlashan T.H., Miller A.L., Perkins D.O., and Kreyenbuhl J. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 161 Suppl. (2) (2004) 1-56
8. Moore T.A., Buchanan R.W., Buckley P.F., Chiles J.A., Conley R.R., Crismon M.L., Essock S.M., Finnerty M., Marder S.R., Miller del D., McEvoy J.P., Robinson D.G., Schooler N.R., Shon S.P., Stroup T.S., and Miller A.L. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. J. Clin. Psychiatry 68 11 (2007) 1751-1762
9. Onishi H., and Yoshida I. Rapid change in Japanese medical education. Med. Teach. 26 5 (2004) 403-408
10. Perkins M.B., Jensen P.S., Jaccard J., Gollwitzer P., Oettingen G., Pappadopulos E., and Hoagwood K.E. Applying theory-driven approaches to understanding and modifying clinicians' behavior: what do we know?. Psychiatr. Serv. 58 3 (2007) 342-348
11. Shiraishi, H., Igarashi, Y., Ikehara, T., Kimura, T., Takeshima, T., Yamamoto, T., Ohi, S., 2000. Law related to mental health and welfare of the person with mental disorder (full text as of date of enforcement in 2000), Translation, 2000.
12. Sim K., Su A., Leong J.Y., Yip K., Chong M.Y., Fujii S., Yang S., Ungvari G.S., Si T., Chung E.K., Tsang H.Y., Shinfuku N., Kua E.H., and Tan C.H. High dose antipsychotic use in schizophrenia: findings of the REAP (research on east Asia psychotropic prescriptions) study. Pharmacopsychiatry 37 4 (2004) 175-179
13. Tateno M., Uchida N., Kikuchi S., Kawada R., Kobayashi S., Nakano W., Sasaki R., Shibata K., Shirasaka T., Suzuki M., Uehara K., and Saito T. The practice of child and adolescent psychiatry: a survey of early-career psychiatrists in Japan. Child Adolesc. Psychiatry Ment. Health 3 1 (2009) 30
14. Tateno M., Sugiura K., Uehara K., Fujisawa D., Zhao Y., Hashimoto N., Takahashi H., Yoshida N., Kato T., Nakano W., Wake Y., Shirasaka T., Kobayashi S., and Sato S. Attitude of young psychiatrists toward coercive measures in psychiatry: a case vignette study in Japan. Int. J. Ment. Health Syst. 3 1 (2009) 20
15. Teo A. The current state of medical education in Japan: a system under reform. Med. Educ. 41 3 (2007) 302-308
16. Tsuchiya K.J., and Takei N. Focus on psychiatry in Japan. Br. J. Psychiatry 184 (2004) 88-92
17. Udomratn P. Prescribing habits of Thai psychiatrists in the treatment of a first episode schizophrenia. J. Psychiatr. Assoc. Thai. 44 2 (1999) 119-124
18. Udomratn P., and Srisurapanont M. Impact on Thai a psychiatrists of passive dissemination of a clinical practice guideline on prescribing attitudes in treatment-resistant schizophrenia. Neuropsychobiology 45 (2002) 186-190
19. Udomratn P., and Ng C.H. Outpatient prescribing practices in Asian countries, in ethno-psychopharmacology. In: Ng C.H., Lin K.M., Singh B.S., and Chiu E. (Eds). Advances in Current Practice (2008), Cambridge University Press, Cambridge 135-143
20. Weinmann S., Hoerger S., Erath M., Kilian R., Gaebel W., and Becker T. Implementation of a schizophrenia practice guideline: clinical results. J. Clin. Psychiatry 69 8 (2008) 1299-1306
21. Yoshimura R., Okamoto T., Nakamura J., Tateno M., Otsuka K., Takahashi H., Fujisawa D., Takamatsu T., Fujii S., Sato S., Inoue M., Sasaki H., Kuroki T., and Shinfuku N. Prescription pattern of antipsychotic drugs for schizophrenic inpatients in Japan: research on East Asia Psychotropic Prescription Pattern-antipsychotics study. Psychiatry Clin. Neurosci. 60 6 (2006) 778-779